Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Vaccine Adjuvants market was valued at 652 Million US$ in 2018 and is projected to reach 1459 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.6% during the forecast period.
This report presents the market size and development trends by detailing the Vaccine Adjuvants market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Vaccine Adjuvants market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Vaccine Adjuvants industry and will help you to build a panoramic view of the industrial development.
Vaccine Adjuvants Market, By Type:
Mineral Salt Based Adjuvants
Tensoactive Adjuvants
Emulsions
Liposomes
Carbohydrates Adjuvants
Bacteria-Derived Adjuvants
Organic Adjuvants
Virus-Like Particles
Others
Vaccine Adjuvants Market, By Application:
Infectious Disease
Therapeutic
Others
Some of the leading players are as follows:
Novavax
Avanti Polar Lipids, Inc
Seppic
Adjuvance
Oz Biosciences
Brenntag AG
Chemtrade Logistics
InvivoGen
SPI Pharma
Aphios
Vaxliant
Adjuvatis
GlaxoSmithKline
Merck KGaA
VaxLiant LLC
Novavax, Inc.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Vaccine Adjuvants Market: Technology Type Analysis
-
4.1 Vaccine Adjuvants Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Vaccine Adjuvants Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Mineral Salt Based Adjuvants
4.3.2 Tensoactive Adjuvants
4.3.3 Emulsions
4.3.4 Liposomes
4.3.5 Carbohydrates Adjuvants
4.3.6 Bacteria-Derived Adjuvants
4.3.7 Organic Adjuvants
4.3.8 Virus-Like Particles
4.3.9 Others
5 Vaccine Adjuvants Market: Product Analysis
-
5.1 Vaccine Adjuvants Product Market Share Analysis, 2018 & 2026
-
5.2 Vaccine Adjuvants Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Vaccine Adjuvants Market: Application Analysis
-
6.1 Vaccine Adjuvants Application Market Share Analysis, 2018 & 2026
-
6.2 Vaccine Adjuvants Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Infectious Disease
6.3.2 Therapeutic
6.3.3 Others
7 Vaccine Adjuvants Market: Regional Analysis
-
7.1 Vaccine Adjuvants Regional Market Share Analysis, 2018 & 2026
-
7.2 Vaccine Adjuvants Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Novavax
9.1.1 Novavax Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Avanti Polar Lipids, Inc
9.2.1 Avanti Polar Lipids, Inc Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Seppic
9.3.1 Seppic Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Adjuvance
9.4.1 Adjuvance Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Oz Biosciences
9.5.1 Oz Biosciences Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Brenntag AG
9.6.1 Brenntag AG Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Chemtrade Logistics
9.7.1 Chemtrade Logistics Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 InvivoGen
9.8.1 InvivoGen Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 SPI Pharma
9.9.1 SPI Pharma Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Aphios
9.10.1 Aphios Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Vaxliant
9.11.1 Vaxliant Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Adjuvatis
9.12.1 Adjuvatis Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 GlaxoSmithKline
9.13.1 GlaxoSmithKline Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Merck KGaA
9.14.1 Merck KGaA Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 VaxLiant LLC
9.15.1 VaxLiant LLC Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Novavax, Inc.
9.16.1 Novavax, Inc. Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
The List of Tables and Figures (Totals 105 Figures and 148 Tables)
Figure Mineral Salt Based Adjuvants Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Tensoactive Adjuvants Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Emulsions Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Liposomes Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Carbohydrates Adjuvants Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Bacteria-Derived Adjuvants Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Organic Adjuvants Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Virus-Like Particles Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Others Vaccine Adjuvants market, 2015 - 2026 (USD Million)
Figure Infectious Disease market, 2015 - 2026 (USD Million)
Figure Therapeutic market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Vaccine Adjuvants market, by country, 2015 - 2026 (USD Million)
-
Table North America Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table North America Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table North America Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Canada Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Canada Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Europe Vaccine Adjuvants market, by country, 2015 - 2026 (USD Million)
-
Table Europe Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Europe Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Europe Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Germany Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Germany Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table France Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table France Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Italy Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Italy Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Spain Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Spain Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Vaccine Adjuvants market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table China Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table China Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Japan Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Japan Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table India Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table India Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Vaccine Adjuvants market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table MEA Vaccine Adjuvants market, by country, 2015 - 2026 (USD Million)
-
Table MEA Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table MEA Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table MEA Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Vaccine Adjuvants market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Vaccine Adjuvants market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Vaccine Adjuvants market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Novavax Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Avanti Polar Lipids, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Seppic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Adjuvance Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Oz Biosciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Brenntag AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Chemtrade Logistics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table InvivoGen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SPI Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aphios Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Vaxliant Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Adjuvatis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck KGaA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table VaxLiant LLC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novavax, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
